NCT03168373Completed
Effect of Intensive Language Therapy in Subacute Stroke Patients
Source: ClinicalTrials.gov · Last updated 7 Mar 2024
Brief summary (registry, in English)
Early stroke rehabilitation is known to be an effective and essential therapy in gaining functional independence and preventing complications. However, there was no consensus of proper amount of language rehabilitation in stroke patients. In this study, the investigators investigated the effects of the intensive language rehabilitation during subacute phase to improve language function in patients with first-ever strokes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 22 May 2017
- Start date
- 1 Nov 2016
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Samsung Medical Center
- Diseases
- Stroke
- NCT number
- NCT03168373
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 1 Nov 2016 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Transient ischemic stroke
Who the study is looking for
- Acute first-ever stroke
- Left hemispheric stroke
- Korean version of Frenchay Aphasia Screening Test(K-FAST) \< 25 (less than 65 years old), K-FAST \<20 (65 years old and more than 65 years old) at 7 days after stroke onset
- Right handedness
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.